Iron Overload: all 156 studies
Page 2 of 2. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization.TerminatedNCT01541813
- Non-invasive Quantification of Liver Iron With MRICompletedNCT01516853
- Iron Metabolism in Small Pre Term NewbornsStatus unknownNCT01443195Not applicable
- Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia MajorCompletedNCT01395199Phase 3
- Observation of Patients With Transfusional Hemosiderosis Treatment With DeferasiroxCompletedNCT01394029
- Changes in Pituitary Iron and Volume With DeferasiroxCompletedNCT01376622
- Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron OverloadCompletedNCT01369719Not applicable
- Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic CirrhosisTerminatedNCT01342705Phase 3
- Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron OverloadCompletedNCT01335035Phase 4
- This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.CompletedNCT01250951Phase 4
- High-Tc Susceptometer to Monitor Transfusional Iron OverloadCompletedNCT01241357
- Iron Mediated Vascular Disease in Sickle Cell Anemia PatientsCompletedNCT01239901
- Assessment of Iron Deposition in Major Organs of Hemodialysis PatientsStatus unknownNCT01169961
- Genes Influencing Iron Overload StateCompletedNCT01158794
- Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* SequencesStatus unknownNCT01121094
- Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of OxidationCompletedNCT01047098Not applicable
- Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic LiversiderosisCompletedNCT01045525Phase 3
- Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron OverloadCompletedNCT01039636Phase 1
- Iron Overload in Pediatric Oncology PatientsCompletedNCT01034072
- Therapeutic Effects of Silymarin in Patients With B-thalassemia MajorStatus unknownNCT00999349Phase 2/3
- Safety of Various Mode of Delivery of Iron Supplement on Iron Toxicity Markers in Preschool ChildrenStatus unknownNCT00980421Phase 3
- Iron Overload and Growth Velocity in Thalassemia and Sickle Cell AnemiaCompletedNCT00972231
- Observational Study of Iron Overload in Stem Cell TransplantationCompletedNCT00954720
- Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)Status unknownNCT00907283Phase 2
- Iron Overload in Patients Undergoing Donor Stem Cell TransplantCompletedNCT00888316
- Iron Overload in Stem Cell Transplant RecipientsCompletedNCT00806715
- Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia MajorCompletedNCT00800761Phase 4
- Oral Nifedipine to Treat Iron OverloadCompletedNCT00712738Phase 1
- Safety and Efficacy of Iron Reduction by PhlebotomyCompletedNCT00689182Phase 2
- Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron OverloadCompletedNCT00654589Phase 4
- Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver DiseaseCompletedNCT00641524Not applicable
- MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.CompletedNCT00629291
- Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron OverloadCompletedNCT00564941Phase 4
- Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron OverloadCompletedNCT00560820Phase 1
- Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512564
- Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512226Not applicable
- Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron OverloadCompletedNCT00481143Phase 4
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With DeferasiroxCompletedNCT00466063
- Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance ImagingCompletedNCT00401336Not applicable
- Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron OverloadCompletedNCT00379483Phase 2
- Study of the Effects of Muscular Activity on Iron MetabolismStatus unknownNCT00378469Not applicable
- Study With Deferiprone and/or Desferrioxamine in Iron Overloaded PatientsCompletedNCT00350662Phase 3
- Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent PatientsCompletedNCT00349453Phase 2
- Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart DiseaseApproved for marketingNCT00293098
- Cytochrome P450 2E1 and Iron OverloadCompletedNCT00138684Phase 2
- Efficacy Study in Removing Excess Iron From the HeartCompletedNCT00105495Phase 4
- Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00067080Phase 2
- Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasCompletedNCT00061763Phase 2
- Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00061750Phase 3
- Treatment of HemochromatosisActive, not recruitingNCT00007150Phase 2
- Hemochromatosis and Iron Overload Screening Study (HEIRS)CompletedNCT00005541
- Combination Iron Chelation TherapyCompletedNCT00004982Phase 1
- Iron Overload in African AmericansCompletedNCT00001455
- Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)CompletedNCT00000623
- Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional HemochromatosisCompletedNCT00000595Phase 2
- Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl HydrazoneCompletedNCT00000588Phase 2